Sarepta Therapeutics Inc (SRPT)

Return on equity (ROE)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	-535,977	-703,488	-418,780	-554,128	-715,075
Total stockholders’ equity	US$ in thousands	859,337	384,950	928,009	761,759	818,187
ROE		-62.37%	-182.75%	-45.13%	-72.74%	-87.40%

December 31, 2023 calculation

ROE = Net income ÷ Total stockholders’ equity
= $-535,977K ÷ $859,337K
= -62.37%

Sarepta Therapeutics Inc's return on equity (ROE) has been volatile over the past five years, ranging from -182.75% to -45.13%. The negative ROE values indicate that the company's net income has not been sufficient to generate a positive return relative to shareholders' equity.

The significant fluctuations in ROE suggest inconsistencies in the company's profitability and efficiency in utilizing shareholders' equity to generate profits. The consistently negative ROE values also raise concerns about the company's financial health and long-term sustainability, as it indicates ongoing challenges in delivering value to shareholders.

Overall, the analysis of Sarepta Therapeutics Inc's ROE highlights the need for the company to improve its profitability and operational efficiency to enhance shareholder value and ensure future growth and stability.